Gloperba (Colchicine) Patent Expiration, LOE Window & CMS Spending

Gloperba (Colchicine) by Scilex: FDA Orange Book LOE 2037-12-20, 17 AB generics, $60K 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorScilex
FDA Application & PathwayN210942 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2037-12-20
Orange Book Patents (*PED Extensions)6 patents (0 *PED)
Active AB-Rated Generic Competitors17
2024 CMS Total Public Spend$60K
2024 Medicare Part D Spend$33K
2024 Medicaid Spend$27K
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel